Seven Years of Safety and Efficacy of the Recombinant Human Growth Hormone Omnitrope® in the Treatment of Growth Hormone Deficient Children: Results of a Phase III Study

Publisher： Karger

E-ISSN： 1663-2826|72|6|359-369

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.72, Iss.6, 2009-10, pp. : 359-369

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Growth Hormone-Deficient Infants with Recombinant Human Growth Hormone to Near-Adult Height: Patterns of Growth

By  

Hormone Research in Paediatrics, Vol. 75, Iss. 4, 2011-01 ,pp. : 276-283

Karger

Access to resources Recommend Favorite

Global Situation of Growth Hormone Treatment in Growth Hormone- Deficient Children

By  

Hormone Research in Paediatrics, Vol. 51, Iss. 3, 2004-11 ,pp. : 75-80

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Growth Hormone Treatment in Children with Hypochondroplasia: Comparison with an Historical Cohort

By  

Hormone Research in Paediatrics, Vol. 82, Iss. 6, 2014-10 ,pp. : 355-363

Karger

Access to resources Recommend Favorite

Safety of High Doses of Recombinant Human Growth Hormone

By  

Hormone Research in Paediatrics, Vol. 49, Iss. 2, 2004-11 ,pp. : 78-81

Karger

Access to resources Recommend Favorite

A Randomized, Double-Blind Study to Assess the Efficacy and Safety of Valtropin, a Biosimilar Growth Hormone, in Children with Growth Hormone Deficiency

By  

Hormone Research in Paediatrics, Vol. 68, Iss. 6, 2007-07 ,pp. : 288-293

Karger

Access to resources Recommend Favorite